# Assessment of Safety and Efficacy of Gabapentin After Surface Ablation, a Case Control Experimental Study

> **NCT06752486** · PHASE1 · RECRUITING · sponsor: **Research Institute of Ophthalmology, Egypt** · enrollment: 64 (estimated)

## Conditions studied

- Pain After Photorefractive Keratectomy
- VAS Will be Used to Assess Pain Postoperative

## Interventions

- **DRUG:** Giving post photorefractive keratectomy for pain relief

## Key facts

- **NCT ID:** NCT06752486
- **Lead sponsor:** Research Institute of Ophthalmology, Egypt
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2025-05-10
- **Final completion:** 2025-06
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2025-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06752486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06752486, "Assessment of Safety and Efficacy of Gabapentin After Surface Ablation, a Case Control Experimental Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06752486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*